Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Journal of Gastrointestinal Cancer|October 22, 2021
Effect of Pressurized Intraperitoneal Aerosol Chemotherapy on the Survival Rate of Patients with Peritoneal Carcinomatosis of Gastric OriginFatah Tidadini, Julio Abba, Jean-Louis Quesada, et al.
World Journal of Surgery|March 14, 2022
An International Registry of Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyFrederic Mercier, Guillaume Passot, Pierre-Emmanuel Bonnot, et al.
Annals of Surgical Oncology|February 2, 2023
Comparison of Neoadjuvant Systemic Chemotherapy Protocols for the Curative-Intent Management of Peritoneal Metastases from Colorectal Cancer, Regarding Morphological Response, Pathological Response, and Long-Term Outcomes: A Retrospective StudyFlorian Fanget, Amaniel Kefleyesus, Julien Peron, et al.
Pleura and Peritoneum|April 6, 2023
Determining a minimum data set for reporting clinical and radiologic data for pseudomyxoma peritoneiThale D J H Patrick-Brown, Faheez Mohamed, Andrew Thrower, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|August 26, 2017
Ninety-day post-operative morbidity and mortality using the National Cancer Institute's common terminology criteria for adverse events better describe post-operative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapyMohammad Alyami, Bradford J Kim, Laurent Villeneuve, et al.
Annals of Surgical Oncology|August 7, 2025
Preoperative Peritoneal MRI: Usefulness to Highlight Potential Hidden Lesions for Complete Cytoreductive Surgery in Patients with Colorectal Cancer with Surgical HistoryBoris Cleret De Langavant, Amaniel Kefleyesus, Julien Peron, et al.
Annals of Surgical Oncology|April 12, 2018
Peritoneal Carcinomatosis of Rare Ovarian Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-Institutional Cohort from PSOGI and BIG-RENAPEFrédéric Mercier, Naoual Bakrin, David L Bartlett, et al.
Anticancer Research|December 4, 2018
No Renal Toxicity After Repeated Treatment with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Unresectable Peritoneal MetastasisVirginie Larbre, Mohammad Alyami, Frederic Mercier, et al.
Annals of Surgical Oncology|December 15, 2017
Peritoneal Carcinomatosis of Urachus Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An International Registry of 36 PatientsFrederic Mercier, Guillaume Passot, Laurent Villeneuve, et al.
International Journal of Colorectal Disease|May 31, 2022
Assessment of postoperative pain after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of peritoneal metastasisFatah Tidadini, Julio Abba, Jean-Louis Quesada, et al.
Pageof 10